• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝内胆管癌的淋巴结转移

Lymph node metastasis in intrahepatic cholangiocarcinoma.

作者信息

Yamamoto M, Takasaki K, Yoshikawa T

机构信息

Department of Gastrointestinal Surgery, Institute of Gastroenterology, Tokyo Women's Medical College, Japan.

出版信息

Jpn J Clin Oncol. 1999 Mar;29(3):147-50. doi: 10.1093/jjco/29.3.147.

DOI:10.1093/jjco/29.3.147
PMID:10225697
Abstract

BACKGROUND

Lymph node metastasis is a significant prognostic factor in intrahepatic cholangiocarcinoma. This study was aimed at investigating lymph node metastasis in intrahepatic cholangiocarcinoma and to examine whether the extent of metastasis affects outcomes after surgery.

METHODS

From 1980 through 1996, 70 patients with intrahepatic cholangiocarcinoma underwent hepatectomy, with a 50% curative resection rate. Lymph node dissection was performed in 51 patients, and the presence of lymph node metastasis was examined microscopically. The metastatic nodes were divided into groups N1, N2 or N3 using the classification proposed by the Liver Cancer Study Group of Japan.

RESULTS

Twenty-three patients had lymph node metastasis. Metastasis was to N1 nodes in 10 patients, to N2 nodes in nine patients and to N3 nodes in four patients. Nineteen patients had metastatic nodes in the hepatoduodenal ligament, which was the most common metastatic site regardless of tumor location. The five-year survival rate in patients with lymph node metastasis (0%) was significantly lower (p < 0.0001) than that in patients without lymph node metastasis (51 %); however, five-year survival rates did not differ between patients with metastases to N1, N2 and N3 nodes.

CONCLUSIONS

Lymph nodes in the hepatoduodenal ligament may be sentinel nodes for intrahepatic cholangiocarcinoma, and outcomes after surgery for patients with lymph node metastasis are poor regardless of the sites of nodal metastasis.

摘要

背景

淋巴结转移是肝内胆管癌的一个重要预后因素。本研究旨在调查肝内胆管癌的淋巴结转移情况,并探讨转移范围是否影响手术后的预后。

方法

1980年至1996年期间,70例肝内胆管癌患者接受了肝切除术,根治性切除率为50%。51例患者进行了淋巴结清扫,并对淋巴结转移情况进行了显微镜检查。根据日本肝癌研究组提出的分类方法,将转移淋巴结分为N1、N2或N3组。

结果

23例患者发生淋巴结转移。10例患者转移至N1组淋巴结,9例患者转移至N2组淋巴结,4例患者转移至N3组淋巴结。19例患者在肝十二指肠韧带出现转移淋巴结,无论肿瘤位置如何,这是最常见的转移部位。有淋巴结转移患者的五年生存率(0%)显著低于无淋巴结转移患者(51%)(p<0.0001);然而,转移至N1、N2和N3组淋巴结患者的五年生存率并无差异。

结论

肝十二指肠韧带的淋巴结可能是肝内胆管癌的前哨淋巴结,无论淋巴结转移部位如何,有淋巴结转移患者的手术后预后均较差。

相似文献

1
Lymph node metastasis in intrahepatic cholangiocarcinoma.肝内胆管癌的淋巴结转移
Jpn J Clin Oncol. 1999 Mar;29(3):147-50. doi: 10.1093/jjco/29.3.147.
2
The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.肝内胆管细胞癌手术后的预后和生存结果:淋巴结转移和淋巴结清扫与生存的关系。
Ann Surg Oncol. 2009 Nov;16(11):3048-56. doi: 10.1245/s10434-009-0631-1. Epub 2009 Jul 22.
3
[Lymph node metastasis of patients with intrahepatic cholangiocarcinoma].[肝内胆管癌患者的淋巴结转移]
Zhonghua Wai Ke Za Zhi. 2006 Apr 1;44(7):454-7.
4
Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma.淋巴结转移数量是肝内胆管癌的一个重要预后因素。
World J Surg. 2005 Jun;29(6):728-33. doi: 10.1007/s00268-005-7761-9.
5
Oncologic Impact of Lymph Node Dissection for Intrahepatic Cholangiocarcinoma: a Propensity Score-Matched Study.肝内胆管癌淋巴结清扫术的肿瘤学影响:一项倾向评分匹配研究。
J Gastrointest Surg. 2019 Mar;23(3):538-544. doi: 10.1007/s11605-018-3899-2. Epub 2018 Aug 15.
6
Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes.评估肝门周围胆管癌的淋巴结状态:位置、数量或受累淋巴结的比例。
Ann Surg. 2013 Apr;257(4):718-25. doi: 10.1097/SLA.0b013e3182822277.
7
Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.乙型肝炎病毒相关性肝内胆管癌切除术后的预后
World J Gastroenterol. 2015 Jan 21;21(3):935-43. doi: 10.3748/wjg.v21.i3.935.
8
Pathological confirmation of para-aortic lymph node status as a potential criterion for the selection of intrahepatic cholangiocarcinoma patients for radical resection with regional lymph node dissection.腹主动脉旁淋巴结状态的病理确认作为选择肝内胆管癌患者进行区域淋巴结清扫根治性切除的潜在标准。
World J Surg. 2014 Jul;38(7):1763-8. doi: 10.1007/s00268-013-2433-7.
9
Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study.淋巴结清扫术对淋巴结阴性的肝内胆管癌长期预后的预测价值:一项多中心研究。
Surgery. 2019 Dec;166(6):975-982. doi: 10.1016/j.surg.2019.06.025. Epub 2019 Aug 14.
10
Prognostic impact of lymph node metastasis in distal cholangiocarcinoma.远端胆管癌淋巴结转移的预后影响。
Br J Surg. 2015 Mar;102(4):399-406. doi: 10.1002/bjs.9752. Epub 2015 Jan 22.

引用本文的文献

1
Impact of Altered Body Composition on Clinical and Oncological Outcomes in Intrahepatic Cholangiocarcinoma.身体成分改变对肝内胆管癌临床和肿瘤学结局的影响
J Clin Med. 2023 Dec 18;12(24):7747. doi: 10.3390/jcm12247747.
2
Intrahepatic cholangiocarcinoma initially diagnosed as adenocarcinoma of unknown primary with hepatoduodenal ligament lymph node metastases: A case report.最初诊断为不明原发腺癌伴肝十二指肠韧带淋巴结转移的肝内胆管癌:一例报告。
Oncol Lett. 2023 Nov 8;27(1):7. doi: 10.3892/ol.2023.14140. eCollection 2024 Jan.
3
The influence of the extent of lymph node metastasis on the prognosis for patients with intrahepatic cholangiocarcinoma.
淋巴结转移范围对肝内胆管癌患者预后的影响。
Ann Surg Treat Res. 2023 May;104(5):258-268. doi: 10.4174/astr.2023.104.5.258. Epub 2023 Apr 28.
4
High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma.肿瘤突变负荷高提示肝内胆管癌患者预后不良。
World J Clin Cases. 2022 Jan 21;10(3):790-801. doi: 10.12998/wjcc.v10.i3.790.
5
Olaparib effectively treats local recurrence of extrahepatic cholangiocarcinoma in a patient harboring a -inactivating mutation: a case report.奥拉帕尼有效治疗携带 BRCA1 失活突变患者的肝外胆管癌局部复发:一例报告
Ann Transl Med. 2021 Sep;9(18):1487. doi: 10.21037/atm-21-3681.
6
Current Surgical Management of Peri-Hilar and Intra-Hepatic Cholangiocarcinoma.肝门周围及肝内胆管癌的当前外科治疗
Cancers (Basel). 2021 Jul 21;13(15):3657. doi: 10.3390/cancers13153657.
7
Clinical outcomes of previously untreated patients with unresectable intrahepatic cholangiocarcinoma following proton beam therapy.质子束治疗不可切除的肝内胆管癌初治患者的临床结果。
Radiat Oncol. 2019 Dec 27;14(1):241. doi: 10.1186/s13014-019-1451-5.
8
Local and abscopal responses in advanced intrahepatic cholangiocarcinoma with low TMB, MSS, pMMR and negative PD-L1 expression following combined therapy of SBRT with PD-1 blockade.局部和远隔效应在低 TMB、MSS、pMMR 和 PD-L1 表达阴性的晚期肝内胆管细胞癌患者中,经 SBRT 联合 PD-1 阻断治疗后的表现。
J Immunother Cancer. 2019 Aug 5;7(1):204. doi: 10.1186/s40425-019-0692-z.
9
Prevalence and clinical significance of regional lymphadenectomy in patients with hepatocellular carcinoma.肝细胞癌患者区域淋巴结清扫术的患病率及临床意义
ANZ J Surg. 2019 Apr;89(4):393-398. doi: 10.1111/ans.15096. Epub 2019 Mar 11.
10
Successful response to the combination of immunotherapy and chemotherapy in cholangiocarcinoma with high tumour mutational burden and PD-L1 expression: a case report.免疫治疗联合化疗治疗高肿瘤突变负荷和 PD-L1 表达的胆管癌获得成功:一例报告。
BMC Cancer. 2018 Nov 12;18(1):1105. doi: 10.1186/s12885-018-5021-2.